Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas.

Bonvalot S, Le Pechoux C, De Baere T, Kantor G, Buy X, Stoeckle E, Terrier P, Sargos P, Coindre JM, Lassau N, Ait Sarkouh R, Dimitriu M, Borghi E, Levy L, Deutsch E, Soria JC.

Clin Cancer Res. 2017 Feb 15;23(4):908-917. doi: 10.1158/1078-0432.CCR-16-1297. Epub 2016 Oct 6.

2.

Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen.

Sedlik C, Heitzmann A, Viel S, Ait Sarkouh R, Batisse C, Schmidt F, De La Rochere P, Amzallag N, Osinaga E, Oppezzo P, Pritsch O, Sastre-Garau X, Hubert P, Amigorena S, Piaggio E.

Oncoimmunology. 2016 Apr 22;5(7):e1171434. doi: 10.1080/2162402X.2016.1171434. eCollection 2016 Jul.

3.

A new delivery system for auristatin in STxB-drug conjugate therapy.

Batisse C, Dransart E, Ait Sarkouh R, Brulle L, Bai SK, Godefroy S, Johannes L, Schmidt F.

Eur J Med Chem. 2015 May 5;95:483-91. doi: 10.1016/j.ejmech.2015.03.047. Epub 2015 Mar 28.

PMID:
25847766

Supplemental Content

Loading ...
Support Center